drug
as of 2026-07-01Linagliptin
MeSH D000069476
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Monash University
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Linagliptin in Schizophrenia Patients
NCT01943019Phase 1Terminated
Linagliptin and Mesenchymal Stem Cells: A Pilot Study
NCT02442817Phase 4Completed
KOLs & investigators
2
Brian Kirkpatrick, MDKOL score 6
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
KOL
Brian Kirkpatrick, MD
personKOL score 6
Maniam Thambu
personKOL score —